Pyoderma Gangrenosum
·MeSH: Pyoderma Gangrenosum
Prevalence
5.0 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| vilobelimab | InflaRx N.V. (IFRX) |
Frequently asked questions
How many drugs are in development for Pyoderma Gangrenosum?
BioSniper tracks 1 drug in development for Pyoderma Gangrenosum across 1 company.
How many clinical trials target Pyoderma Gangrenosum?
There are 1 clinical trial targeting Pyoderma Gangrenosum tracked by BioSniper.
What is the prevalence of Pyoderma Gangrenosum?
The estimated prevalence of Pyoderma Gangrenosum is approximately 5.0 per 100,000 population.
Deep-dive into Pyoderma Gangrenosum
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis